雷公藤甲素药代动力学研究进展

被引:10
作者
邰婷 [1 ]
江振洲 [2 ,3 ]
黄鑫 [2 ,3 ]
吉金子 [1 ]
张陆勇 [1 ,3 ]
机构
[1] 中国药科大学江苏省新药筛选中心
[2] 中国药科大学药物质量与安全预警教育部重点实验室
[3] 江苏省药效研究与评价服务中心
关键词
雷公藤甲素; 药代动力学; 毒性; 衍生物; 制剂;
D O I
10.13664/j.cnki.pcr.2012.03.009
中图分类号
R285 [中药药理学];
学科分类号
100806 [中药药理学];
摘要
雷公藤甲素(TP)作为雷公藤的主要活性成分,具有抗炎、免疫抑制、抗生育、抗囊肿和抗肿瘤等作用,但其治疗窗窄,对消化系统、泌尿生殖系统和血液系统等有较大的毒副作用,因此临床开发研究受到了一定限制。本文主要针对TP药代动力学的研究进行整理和归纳,并概述了基于改善TP体内药动学特性所研发的新型TP衍生物和相关制剂,以期为TP的新药开发研究提供助益。
引用
收藏
页码:229 / 235
页数:7
相关论文
共 30 条
[1]
Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo [J].
Li, Chia-Jung ;
Chu, Ching-Yu ;
Huang, Lin-Huang ;
Wang, Ming-Hseng ;
Sheu, Lai-Fa ;
Yeh, Jih-I. ;
Hsu, Hsue-Yin .
CANCER LETTERS, 2012, 319 (02) :203-213
[2]
Triptolide and its expanding multiple pharmacological functions [J].
Liu, Qiuyan .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (03) :377-383
[3]
Knockout of hepatic P450 reductase aggravates triptolide-induced toxicity [J].
Xue, Xiang ;
Gong, Likun ;
Qi, Xinming ;
Wu, Yuanfeng ;
Xing, Guozhen ;
Yao, Jun ;
Luan, Yang ;
Xiao, Ying ;
Li, Yan ;
Wu, Xiongfei ;
Chen, Min ;
Gu, Jun ;
Ren, Jin .
TOXICOLOGY LETTERS, 2011, 205 (01) :47-54
[4]
Disappearance of sexual dimorphism in triptolide metabolism in monosodium glutamate treated neonatal rats [J].
Liu, Li ;
Jiang, Zhenzhou ;
Huang, Xiaofeng ;
Liu, Jing ;
Zhang, Juan ;
Xiao, Jingwei ;
Bao, Qingli ;
Wen, Jing ;
Zhang, Shuang ;
Zhu, Dan ;
Zhang, Pinghu ;
Zhang, Luyong .
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2011, 61 (02) :98-103
[5]
Triptolide Induces Cell Death in Pancreatic Cancer Cells by Apoptotic and Autophagic Pathways [J].
Mujumdar, Nameeta ;
Mackenzie, Tiffany N. ;
Dudeja, Vikas ;
Chugh, Rohit ;
Antonoff, Mara B. ;
Borja-Cacho, Daniel ;
Sangwan, Veena ;
Dawra, Rajinder ;
Vickers, Selwyn M. ;
Saluja, Ashok K. .
GASTROENTEROLOGY, 2010, 139 (02) :598-608
[6]
Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats.[J].Li Liu;Zhenzhou Jiang;Jing Liu;Xin Huang;Tao Wang;Jun Liu;Yun Zhang;Zhixing Zhou;Jianlu Guo;Lina Yang;Yun Chen;Luyong Zhang.Toxicology.2010, 1
[7]
Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours [J].
Kitzen, J. J. E. M. ;
de Jonge, M. J. A. ;
Lamers, C. H. J. ;
Eskens, F. A. L. M. ;
van der Biessen, D. ;
van Doorn, L. ;
ter Steeg, J. ;
Brandely, M. ;
Puozzo, Ch. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (10) :1764-1772
[8]
Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo [J].
Antonoff, Mara B. ;
Chugh, Rohit ;
Borja-Cacho, Daniel ;
Dudeja, Vikas ;
Clawson, Kimberly A. ;
Skube, Steven J. ;
Sorenson, Brent S. ;
Saltzman, Daniel A. ;
Vickers, Selwyn M. ;
Saluja, Ashok K. .
SURGERY, 2009, 146 (02) :282-290
[9]
Male Reproductive Toxicity and Toxicokinetics of Triptolide in Rats [J].
Ni, Bin ;
Jiang, Zhenzhou ;
Huang, Xin ;
Xu, Fengguo ;
Zhang, Rui ;
Zhang, Zunjian ;
Tian, Yuan ;
Wang, Tao ;
Zhu, Tian ;
Liu, Jing ;
Zhang, Luyong .
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2008, 58 (12) :673-680
[10]
Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes [J].
Li, W. ;
Liu, Y. ;
He, Y. -Q. ;
Zhang, J. -W. ;
Gao, Y. ;
Ge, G. -B. ;
Liu, H. -X. ;
Huo, H. ;
Liu, H. -T. ;
Wang, L. -M. ;
Sun, J. ;
Wang, Q. ;
Yang, L. .
XENOBIOTICA, 2008, 38 (12) :1551-1565